Document Detail


Current and emerging therapies for Addison's disease.
MedLine Citation:
PMID:  24755997     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: The purpose of this article is to review the current therapy of Addison's disease and to highlight recent developments in this field.
RECENT FINDINGS: Conventional steroid replacement for Addison's disease consists of twice or three-times daily oral hydrocortisone and once-daily fludrocortisone; however, new treatment modalities such as modified-released hydrocortisone and continuous subcutaneous hydrocortisone infusion have recently been developed. These offer the potential for closer simulation of the physiological serum cortisol rhythm. Two studies have also looked at modifying the natural history of adrenal failure using adrenocorticotropic hormone (ACTH) stimulation and immunomodulatory therapies, leading to the concept of residual adrenal function in some Addison's disease patients.
SUMMARY: Following more than 60 years with no significant innovation in the management of Addison's disease, these new approaches hold promise for improved patient health and better quality of life in the future.
Authors:
Catherine Napier; Simon H S Pearce
Related Documents :
2592797 - Vascular manifestations of behçet's disease.
15461067 - Frequency of non-vascular accompanying diseases in patients with peripheral arterial di...
14647877 - Drug-eluting stents in peripheral vascular disease: eliminating restenosis.
15725237 - Reticulate hyperpigmented scleroderma: a new pigmentary manifestation.
18587587 - Achalasia-like findings in a case with delayed diagnosis of h-type tracheoesophageal fi...
16472207 - Amyloid beta: the alternate hypothesis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current opinion in endocrinology, diabetes, and obesity     Volume:  21     ISSN:  1752-2978     ISO Abbreviation:  Curr Opin Endocrinol Diabetes Obes     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-04-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101308636     Medline TA:  Curr Opin Endocrinol Diabetes Obes     Country:  England    
Other Details:
Languages:  eng     Pagination:  147-53     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association of Veterinary Third-Generation Cephalosporin Use with the Risk of Emergence of Extended-...
Next Document:  Management of female-to-male transgender persons: medical and surgical management, life expectancy.